Accepted for Publication: March 14, 2022.
Corresponding Author: Jennifer S. Lin, MD, Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente Northwest, 3800 N Interstate Ave, Portland, OR 97227 (email@example.com).
Author Contributions: Ms Webber and Dr Lin had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Webber, Lin.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Webber.
Critical revision of the manuscript for important intellectual content: All authors.
Obtained funding: Lin.
Administrative, technical, or material support: Webber, Thomas.
Conflict of Interest Disclosures: None reported.
Funding/Support: This research was funded under HHSA290201500007I, Task Order 9, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the US Preventive Services Task Force (USPSTF).
Role of the Funder/Sponsor: Investigators worked with USPSTF members and AHRQ staff to develop the scope, analytic framework, and key questions for this review. AHRQ had no role in study selection, quality assessment, or synthesis. AHRQ staff provided project oversight, reviewed the report to ensure that the analysis met methodological standards, and distributed the draft for peer review. Otherwise, AHRQ had no role in the conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript findings. The opinions expressed in this document are those of the authors and do not reflect the official position of AHRQ or the US Department of Health and Human Services.
Additional Contributions: We thank the following for their contributions to this project: the AHRQ staff; the US Preventive Services Task Force; and Melinda Davies, MAIS, and Jill Pope, BA (Kaiser Permanente Center for Health Research), for technical and editorial assistance. The USPSTF members, peer reviewers, and federal partner reviewers did not receive financial compensation for their contributions.
Additional Information: A draft version of this evidence report underwent external peer review from 3 content experts (Jerry Krishnan MD, PhD, University of Illinois Chicago; Richard Mularski, MD, MSHS, MCR, Kaiser Permanente Northwest; Barbara Yawn, MD, MSc, University of Minnesota) and 1 federal partner (Centers for Disease Control and Prevention). Comments were presented to the USPSTF during its deliberation of the evidence and were considered in preparing the final evidence review.
Editorial Disclaimer: This evidence report is presented as a document in support of the accompanying USPSTF Recommendation Statement. It did not undergo additional peer review after submission to JAMA.
Centers for Disease Control and Prevention. Chronic obstructive pulmonary disease (COPD): data and statistics. Published 2021. Accessed September 15, 2021. https://www.cdc.gov/copd/data.html
AL , Bibbins-Domingo
K , Grossman
et al; US Preventive Services Task Force (USPSTF). Screening for chronic obstructive pulmonary disease: US Preventive Services Task Force Recommendation Statement. JAMA
. 2016;315(13):1372-1377. doi:10.1001/jama.2016.2638PubMedGoogle ScholarCrossref
JM , Senger
CA , Webber
EM , Mularski
RA , Whitlock
EP . Screening for chronic obstructive pulmonary disease: evidence report and systematic review for the US Preventive Services Task Force. JAMA
. 2016;315(13):1378-1393. doi:10.1001/jama.2016.2654PubMedGoogle ScholarCrossref
JS , Webber
EM , Thomas
RG . Screening for Chronic Obstructive Pulmonary Disease: A Targeted Evidence Update for the US Preventive Services Task Force. Evidence Synthesis No. 215. Agency for Healthcare Research and Quality; 2022. AHRQ publication 21-05287-EF-1.
J , Anderson
JA , Brook
et al; SUMMIT Investigators. Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial. Lancet
. 2016;387(10030):1817-1826. doi:10.1016/S0140-6736(16)30069-1PubMedGoogle ScholarCrossref
FJ , Rabe
KF , Lipworth
et al. Glycopyrrolate/formoterol fumarate metered dose inhaler improves lung function versus monotherapies in GOLD category A patients with COPD: pooled data from the phase III PINNACLE studies. Int J Chron Obstruct Pulmon Dis
. 2020;15:99-106. doi:10.2147/COPD.S229794PubMedGoogle ScholarCrossref
EW , Akkermans
R , Bourbeau
J , van Weel
C , Vercoulen
JH , Schermer
TR . Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial. BMJ
. 2012;345:e7642. doi:10.1136/bmj.e7642PubMedGoogle ScholarCrossref
SWM , Schuurmans
MJ , Zanen
P , Heijmans
MJWM , Sachs
APE , Lammers
JJ . The effectiveness of a nurse-led illness perception intervention in COPD patients: a cluster randomised trial in primary care. ERJ Open Res
. 2017;3(4):00115-2016. doi:10.1183/23120541.00115-2016PubMedGoogle ScholarCrossref
A , Tistad
M , Wadell
K . Can the COPD web be used to promote self-management in patients with COPD in swedish primary care: a controlled pragmatic pilot trial with 3-month and 12-month follow-up. Scand J Prim Health Care
. 2019;37(1):69-82. doi:10.1080/02813432.2019.1569415PubMedGoogle ScholarCrossref
V , Tange
H , de Vries
H , Nagykaldi
Z , Winkens
B , van der Weijden
T . A randomized controlled trial evaluating the effectiveness of a web-based, computer-tailored self-management intervention for people with or at risk for COPD. Int J Chron Obstruct Pulmon Dis
. 2015;10:1061-1073. doi:10.2147/COPD.S81295PubMedGoogle ScholarCrossref
ML , Martinez
CH , Kadri
et al. Long-term effects of an internet-mediated pedometer-based walking program for chronic obstructive pulmonary disease: randomized controlled trial. J Med Internet Res
. 2016;18(8):e215. doi:10.2196/jmir.5622PubMedGoogle ScholarCrossref
WA , ten Hacken
NH , Bossenbroek
L , Kerstjens
HA , de Greef
MH , Wempe
JB . Short- and long-term effects of a physical activity counselling programme in COPD: a randomized controlled trial. Respir Med
. 2015;109(1):112-121. doi:10.1016/j.rmed.2014.10.020PubMedGoogle ScholarCrossref
DMG , Tashkin
DP , Celli
BR , Leimer
I , Metzdorf
N , Decramer
M . Effect of tiotropium on outcomes in patients with COPD, categorized using the new GOLD grading system: results of the UPLIFT® randomized controlled trial. Chronic Obstr Pulm Dis
. 2015;2(3):236-251. doi:10.15326/jcopdf.2.3.2014.0142PubMedGoogle ScholarCrossref
BP , Han
M , Make
et al. Protocol summary of the COPD Assessment in Primary care To identify Undiagnosed Respiratory disease and Exacerbation risk (CAPTURE) validation in primary care study. Chronic Obstr Pulm Dis
. 2021;8(1):60-75. doi:10.15326/jcopdf.2020.0155PubMedGoogle ScholarCrossref